Amylyx Pharmaceuticals, Inc. (AMLX) NASDAQ
14.95
+0.6(+4.18%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.95
+0.6(+4.18%)
Currency In USD
| Market Cap | 1.14B |
| Enterprise Value | 921.66M |
| P/E Ratio | -9.77 |
| PEG Ratio | -0.65 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.63 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -7.09 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.44 |
| Return On Equity | -0.58 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -525,000 |
| EBITDA | -144.16M |
| Net Income | -144.74M |
| Diluted EPS | -1.53 |
| Total Cash | 316.98M |
| Total Cash/Share | 3.35 |
| Total Debt | 5.96M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 14.27 |
| Book Value Per Share | 3.23 |
| 52-Week Change | 325.93 |
| 52-Week High | 17.49 |
| 52-Week Low | 3.11 |
| Moving Average 50 Days | 14.37 |
| Moving Average 200 Days | 12.01 |
| Average Volume | 1.26M |
| Shares Outstanding | 83.13M |
| % Held by Institutions | 120.34 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |